Project Grant R41DC022504

Award Date 4/15/25
Completion Date 3/31/26
Dollars Obligated $305K
Federal Grant Program
93.173
Assistance Type
Project Grant
Place of Performance
California, USA
Similar Awards
The Project Grant award R43DC021615 was provided by the National Institute on Deafness and Other Communication Disorders (NIDCD) under the Research Related to Deafness and Communication Disorders Federal Grant Program (CFDA 93.173). The $275,371 award to Auricle Health Inc. in Oakland, CA will fund the development of an extracochlear device to restore high-frequency hearing for patients with sensorineural hearing loss, a condition affecting over 460 million people worldwide. In Phase I, the...
This $1,008,234 federal Project Grant award was provided by the National Institute on Deafness and Other Communication Disorders (NIDCD) under the Research Related to Deafness and Communication Disorders federal grant program (CFDA 93.173). The award will support research investigating objective neural correlates of two types of subjective tinnitus - non-somatic tinnitus and somatic (somatosensory) tinnitus - using functional near-infrared spectroscopy (fNIRS) neuroimaging. The project aims to...
This Project Grant award from the National Institute on Deafness and Other Communication Disorders (NIDCD), under the federal grant program "Research Related to Deafness and Communication Disorders" (CFDA 93.173), aims to investigate whether tinnitus can be subtyped based on brain functional connectivity. The $134,730 award will support research at Massachusetts General Hospital to analyze functional MRI (fMRI) datasets from the UK Biobank and an additional 7T fMRI dataset to...
The National Institute on Deafness and Other Communication Disorders (NIDCD) awarded a $277,810 Project Grant under the Research Related to Deafness and Communication Disorders program (CFDA 93.173) to Femtovox Incorporated, a for-profit organization located in Ladera Ranch, CA. The funding supports the development of an image-guided automated ultrafast laser device for laryngeal (voice box) surgery. The device is designed to provide real-time optical coherence tomography (OCT) imaging to...
This Project Grant award from the National Institute on Deafness and Other Communication Disorders (NIDCD), under the Research Related to Deafness and Communication Disorders program (CFDA 93.173), provides $306,073 to Iotamotion, Inc. to develop a navigation-based cochlear implant insertion system. The system is designed to optimize the trajectory and control the speed of electrode array insertion during cochlear implantation procedures, with the goal of preserving inner ear structures and...
This Project Grant award from the National Institute on Deafness and Other Communication Disorders (NIDCD), under the Research Related to Deafness and Communication Disorders program (CFDA 93.173), will fund the development of a cell-type-specific gene therapy approach for TOMT-linked congenital hearing loss. The $305,628 award to Echogenesis Therapeutics Inc. aims to establish the efficacy of their AAV-based, hair-cell-specific gene therapy in restoring hearing in TOMT mutant mice. The key...
This federal Project Grant award from the National Institute on Deafness and Other Communication Disorders (NIDCD), under the Research Related to Deafness and Communication Disorders program (CFDA 93.173), will support research to investigate the neural basis of tinnitus and hyperacusis. The $145,989 award, effective May 1, 2025 through April 30, 2030, will enable the principal investigator, Dr. Sarah Hayes, to utilize animal models and advanced in vivo imaging techniques to determine if altered...
This $290,920 federal Project Grant awarded by the National Institute on Deafness and Other Communication Disorders (NIDCD) under the Research Related to Deafness and Communication Disorders program (CFDA 93.173) aims to develop a novel treatment for noise-induced hearing loss (NIHL). The grant recipient, Dermaxon LLC, a biotech company in Missoula, Montana, will pursue research to identify a selective CYP26 inhibitor that can increase retinoic acid levels in the inner ear and promote the...
Pionear Technologies Inc. received a $699,002 Project Grant award from the National Institute on Deafness and Other Communication Disorders within the Department of Health and Human Services. The award is part of the Research Related to Deafness and Communication Disorders federal grant program (CFDA 93.173) to develop novel liquid-infused tympanostomy tubes with optimized lumen geometry and slippery material design. The goal of the project is to engineer tympanostomy tubes that more efficiently...
This $498,000 Project Grant award from the National Institute on Deafness and Other Communication Disorders (NIDCD), under the Research Related to Deafness and Communication Disorders program (CFDA 93.173), supports research to develop an ex-vivo porcine round window membrane (RWM) model and evaluate nanovesicles for enhanced, non-surgical delivery of therapeutics into the inner ear. The primary objectives are to: 1) validate the porcine RWM model for drug permeability, 2) identify...

This $305,197 Project Grant awarded by the National Institute on Deafness and Other Communication Disorders (NIDCD) under the Research Related to Deafness and Communication Disorders program (CFDA 93.173) aims to develop a novel medical device called PHONOCATH. The device is designed to provide a minimally invasive, patient-friendly approach to diagnosing pulsatile tinnitus, a form of tinnitus characterized by a heartbeat-synchronous sound that can lead to severe depression or anxiety in 60% of patients.

The key objectives of this Phase I STTR project are to: 1) design and produce a new PHONOCATH microcatheter prototype, 2) validate the device using in vitro 3D printed flow models, and 3) validate the pulsatile tinnitus evaluation procedure using hybrid models combining 3D printed bodies and human cadaver heads. These activities are critical steps towards producing PHONOCATH devices ready for regulatory verification and validation, with the ultimate goal of commercializing the system and transforming the standard of care for pulsatile tinnitus patients.

Generated 4/29/25, 1:58 AM